Met Life Investment Management, LLC Avrobio, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$3.45 - $6.05 $50,559 - $88,662	-14,655 Closed	0 $0
Q3 2021 May 17, 2024	BUY	$5.53 - $9.28 $72,736 - $122,059	13,153 Added 875.7%	14,655 $81,000
Q3 2021 Jun 21, 2023	BUY	$5.53 - $9.28 $81,042 - $135,998	14,655 New	14,655 $81,000
Q3 2021 Mar 22, 2023	BUY	$5.53 - $9.28 $72,736 - $122,059	13,153 Added 875.7%	14,655 $81,000
Q3 2021 Nov 15, 2021	BUY	$5.53 - $9.28 $72,736 - $122,059	13,153 Added 875.7%	14,655 $82,000
Q2 2021 May 17, 2024	SELL	$7.84 - $12.6 $96,800 - $155,572	-12,347 Reduced 89.15%	1,502 $13,000
Q2 2021 Jun 21, 2023	BUY	$7.84 - $12.6 $11,775 - $18,925	1,502 New	1,502 $13,000
Q2 2021 Mar 22, 2023	SELL	$7.84 - $12.6 $96,800 - $155,572	-12,347 Reduced 89.15%	1,502 $13,000
Q2 2021 Aug 16, 2021	SELL	$7.84 - $12.6 $96,800 - $155,572	-12,347 Reduced 89.15%	1,502 $13,000
Q1 2021 May 17, 2024	BUY	$10.54 - $19.3 $145,968 - $267,285	13,849 New	13,849 $175,000
Q1 2021 Jun 26, 2023	BUY	$10.54 - $19.3 $145,968 - $267,285	13,849 New	13,849 $176 Million
Q1 2021 Mar 22, 2023	SELL	$10.54 - $19.3 $5,659 - $10,364	-537 Reduced 3.73%	13,849 $175,000
Q1 2021 May 14, 2021	SELL	$10.54 - $19.3 $5,659 - $10,364	-537 Reduced 3.73%	13,849 $176,000
Q4 2020 Jun 22, 2023	BUY	$12.79 - $17.1 $183,996 - $246,000	14,386 New	14,386 $200,000
Q3 2020 Jun 26, 2023	BUY	$12.99 - $19.41 $186,874 - $279,232	14,386 New	14,386 $187,000
Q2 2020 May 24, 2024	BUY	$12.19 - $22.96 $175,365 - $330,302	14,386 New	14,386 $251 Million
Q2 2020 Jun 26, 2023	BUY	$12.19 - $22.96 $175,365 - $330,302	14,386 New	14,386 $251,000
Q2 2020 Mar 22, 2023	BUY	$12.19 - $22.96 $41,872 - $78,867	3,435 Added 31.37%	14,386 $251,000
Q2 2020 Aug 14, 2020	BUY	$12.19 - $22.96 $41,872 - $78,867	3,435 Added 31.37%	14,386 $251,000
Q1 2020 Jul 12, 2023	BUY	$10.08 - $27.21 $110,386 - $297,976	10,951 New	10,951 $170,000
Q1 2020 Mar 22, 2023	BUY	$10.08 - $27.21 $24,544 - $66,256	2,435 Added 28.59%	10,951 $170,000
Q1 2020 May 15, 2020	BUY	$10.08 - $27.21 $24,544 - $66,256	2,435 Added 28.59%	10,951 $170,000
Q4 2019 Jul 12, 2023	BUY	$13.05 - $21.88 $111,133 - $186,330	8,516 New	8,516 $171,000
Q3 2019 Jul 12, 2023	BUY	$14.12 - $23.44 $120,245 - $199,615	8,516 New	8,516 $120,000
Q3 2019 Mar 22, 2023	BUY	$14.12 - $23.44 $8,599 - $14,274	609 Added 7.7%	8,516 $120,000
Q3 2019 Nov 14, 2019	BUY	$14.12 - $23.44 $120,245 - $199,615	8,516 New	8,516 $120,000
Q2 2019 Jul 12, 2023	BUY	$13.21 - $27.29 $112,496 - $232,401	8,516 New	8,516 $138 Million
Q4 2018 Feb 14, 2019	SELL	$15.43 - $32.7 $122,005 - $258,558	-7,907 Closed	0 $0
Q3 2018 Jul 13, 2023	BUY	$26.95 - $52.7 $136,097 - $266,135	5,050 New	5,050 $261,000
Q3 2018 Mar 22, 2023	BUY	$26.95 - $52.7 $213,093 - $416,698	7,907 New	7,907 $410,000
Q3 2018 Nov 14, 2018	BUY	$26.95 - $52.7 $213,093 - $416,698	7,907 New	7,907 $410,000

Others Institutions Holding AVRO

# of Institutions

Shares Held

559K

Call Options Held

Put Options Held

Terrapin Asset Management, LLC Miami, FL

559K
Shares

$0
0.98% of portfolio

View Full List

About AVROBIO, Inc.

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

More about AVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account